Lista de obras -

ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis

artículo científico publicado en 2011

Alström Syndrome: Cardiac Magnetic Resonance findings ⬇️

artículo científico publicado el 10 de abril de 2012

Alström Syndrome: Mutation Spectrum of ALMS1.

artículo científico publicado en 2015

Alström syndrome: genetics and clinical overview

artículo científico publicado en 2011

Ambulatory arterial stiffness indexes in acromegaly

artículo científico publicado en 2011

Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome

artículo científico publicado en 2014

Brain involvement in Alström syndrome

artículo científico publicado en 2013

CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly

artículo científico publicado en 2006

Clinical and diagnostic aspects of cystic insulinoma

artículo científico publicado en 2005

Clinical utility gene card for: Alström Syndrome - update 2013.

artículo científico publicado en 2013

Clinical utility gene card for: Alström syndrome ⬇️

artículo científico publicado el 27 de abril de 2011

Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy.

artículo científico publicado en 2017

Coronary microvascular function in patients with Cushing’s syndrome ⬇️

artículo científico publicado el 1 de agosto de 2012

Correction to: Pegvisomant in acromegaly: an update.

artículo científico publicado en 2017

Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome.

artículo científico publicado en 2015

EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome

artículo científico publicado en 2013

Effects of Amanita phalloides toxins on insulin release: in vivo and in vitro studies

artículo científico publicado en 2003

Effects of octreotide exposure during pregnancy in acromegaly

artículo científico publicado en 2009

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly

artículo científico publicado en 2002

Emergency pacemaker implantation in acromegaly

artículo científico publicado en 2004

Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.

artículo científico publicado en 2014

Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients

artículo científico publicado en 2004

GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance

artículo científico publicado en 2014

HIGH-DOSE AND HIGH-FREQUENCY LANREOTIDE AUTOGEL IN ACROMEGALY: A RANDOMIZED, MULTICENTER STUDY.

artículo científico publicado en 2017

Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact.

artículo científico publicado en 2013

High-Resolution Spectral Domain Optical Coherence Tomography Images of Alström Syndrome ⬇️

artículo científico publicado el 21 de mayo de 2010

How to improve effectiveness of pegvisomant treatment in acromegalic patients.

artículo científico publicado en 2017

Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature

artículo científico publicado en 2011

Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance

artículo científico publicado en 2012

Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment

scientific article published on 12 June 2014

Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study

artículo científico publicado en 2014

Late potentials and ventricular arrhythmias in acromegaly

artículo científico publicado en 2005

Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant

artículo científico publicado en 2006

Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia

artículo científico publicado en 2017

Multidisciplinary management of acromegaly: A consensus

artículo científico publicado en 2020

Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing

artículo científico publicado en 2016

Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome

scientific journal article

Neuroendocrine tumor of small bowel

artículo científico publicado en 2004

New Alström syndrome phenotypes based on the evaluation of 182 cases

artículo científico publicado en 2005

Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis

scientific article published on 01 March 2020

Ovarian tumors secreting insulin

artículo científico publicado en 2015

Pegvisomant in acromegaly: an update

artículo científico publicado en 2017

Pegvisomant in acromegaly: why, when, how.

artículo científico publicado en 2007

Persistent Reduction of Circulating Myeloid Calcifying Cells in Acromegaly: Relevance to the Bone-Vascular Axis

artículo científico publicado en 2017

Pituitary morphovolumetric changes in Alström syndrome

artículo científico publicado en 2015

Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis

scientific article published on 01 December 2018

Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes

artículo científico publicado en 2008

Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes.

artículo científico publicado en 2018

Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity.

artículo científico publicado en 2008

Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid

artículo científico publicado en 2005

Sudden death due to aortic rupture in acromegaly

scientific article published on 01 January 2008

Syndromic obesity: clinical implications of a correct diagnosis.

artículo científico publicado en 2014

The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway

artículo científico publicado en 2012

The Alström syndrome: is it a rare or unknown disease?

artículo científico publicado en 2002

The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy ⬇️

artículo científico publicado el 1 de marzo de 2011

The progression from obesity to type 2 diabetes in Alström syndrome.

artículo científico publicado en 2011

Transient false-negative tc-99m sestamibi parathyroid scintigraphy following total thyroidectomy

artículo científico publicado en 2005

[Growth hormone deficiency in the adult: only an endocrinologic problem?]

artículo científico publicado en 2002

Lista de obras de

ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis

Alström Syndrome: Cardiac Magnetic Resonance findings ⬇️

Alström Syndrome: Mutation Spectrum of ALMS1.

Alström syndrome: genetics and clinical overview

Ambulatory arterial stiffness indexes in acromegaly

Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome

Brain involvement in Alström syndrome

CYP11B2 -344T/C gene polymorphism and blood pressure in patients with acromegaly

Clinical and diagnostic aspects of cystic insulinoma

Clinical utility gene card for: Alström Syndrome - update 2013.

Clinical utility gene card for: Alström syndrome ⬇️

Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy.

Coronary microvascular function in patients with Cushing’s syndrome ⬇️

Correction to: Pegvisomant in acromegaly: an update.

Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome.

EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome

Effects of Amanita phalloides toxins on insulin release: in vivo and in vitro studies

Effects of octreotide exposure during pregnancy in acromegaly

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly

Emergency pacemaker implantation in acromegaly

Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.

Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients

GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance

HIGH-DOSE AND HIGH-FREQUENCY LANREOTIDE AUTOGEL IN ACROMEGALY: A RANDOMIZED, MULTICENTER STUDY.

Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact.

High-Resolution Spectral Domain Optical Coherence Tomography Images of Alström Syndrome ⬇️

How to improve effectiveness of pegvisomant treatment in acromegalic patients.

Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature

Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance

Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment

Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study

Late potentials and ventricular arrhythmias in acromegaly

Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant

Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia

Multidisciplinary management of acromegaly: A consensus

Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing

Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome

Neuroendocrine tumor of small bowel

New Alström syndrome phenotypes based on the evaluation of 182 cases

Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis

Ovarian tumors secreting insulin

Pegvisomant in acromegaly: an update

Pegvisomant in acromegaly: why, when, how.

Persistent Reduction of Circulating Myeloid Calcifying Cells in Acromegaly: Relevance to the Bone-Vascular Axis

Pituitary morphovolumetric changes in Alström syndrome

Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis

Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes

Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes.

Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity.

Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid

Sudden death due to aortic rupture in acromegaly

Syndromic obesity: clinical implications of a correct diagnosis.

The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway

The Alström syndrome: is it a rare or unknown disease?

The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy ⬇️

The progression from obesity to type 2 diabetes in Alström syndrome.

Transient false-negative tc-99m sestamibi parathyroid scintigraphy following total thyroidectomy

[Growth hormone deficiency in the adult: only an endocrinologic problem?]